ID   SGPP2_HUMAN             Reviewed;         399 AA.
AC   Q8IWX5; A3KPB4; Q8N8Q6;
DT   10-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   10-MAY-2017, entry version 114.
DE   RecName: Full=Sphingosine-1-phosphate phosphatase 2;
DE            Short=SPPase2;
DE            Short=Spp2;
DE            Short=hSPP2;
DE            EC=3.1.3.-;
DE   AltName: Full=Sphingosine-1-phosphatase 2;
GN   Name=SGPP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=12411432; DOI=10.1074/jbc.M209514200;
RA   Ogawa C., Kihara A., Gokoh M., Igarashi Y.;
RT   "Identification and characterization of a novel human sphingosine-1-
RT   phosphate phosphohydrolase, hSPP2.";
RL   J. Biol. Chem. 278:1268-1272(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=17113265; DOI=10.1016/j.cellsig.2006.09.004;
RA   Mechtcheriakova D., Wlachos A., Sobanov J., Kopp T., Reuschel R.,
RA   Bornancin F., Cai R., Zemann B., Urtz N., Stingl G., Zlabinger G.,
RA   Woisetschlager M., Baumruker T., Billich A.;
RT   "Sphingosine 1-phosphate phosphatase 2 is induced during inflammatory
RT   responses.";
RL   Cell. Signal. 19:748-760(2007).
CC   -!- FUNCTION: Has specific phosphohydrolase activity towards sphingoid
CC       base 1-phosphates. Has high phosphohydrolase activity against
CC       dihydrosphingosine-1-phosphate and sphingosine-1-phosphate (S1P)
CC       in vitro. May play a role in attenuating intracellular sphingosine
CC       1-phosphate (S1P) signaling. May play a role in pro-inflammatory
CC       signaling. {ECO:0000269|PubMed:12411432,
CC       ECO:0000269|PubMed:17113265}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:12411432}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:12411432}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8IWX5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IWX5-2; Sequence=VSP_039385;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed strongly in kidney and heart,
CC       followed by brain, colon, small intestine and lung. Not detected
CC       in skeletal muscle, thymus, spleen, liver, placenta, and
CC       peripheral blood leukocytes. {ECO:0000269|PubMed:12411432}.
CC   -!- INDUCTION: Strongly induced by TNF, also induced by bacterial
CC       lipopolycaccharides (LPS) in neutrophils, endothelial cells, and
CC       other cell types. Not induced by growth-related factors.
CC       {ECO:0000269|PubMed:17113265}.
CC   -!- SIMILARITY: Belongs to the type 2 lipid phosphate phosphatase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF542512; AAN28731.1; -; mRNA.
DR   EMBL; AK096323; BAC04762.1; -; mRNA.
DR   EMBL; AK314322; BAG36970.1; -; mRNA.
DR   EMBL; BC134342; AAI34343.1; -; mRNA.
DR   CCDS; CCDS2453.1; -. [Q8IWX5-1]
DR   RefSeq; NP_001307762.1; NM_001320833.1. [Q8IWX5-2]
DR   RefSeq; NP_001307763.1; NM_001320834.1. [Q8IWX5-2]
DR   RefSeq; NP_689599.2; NM_152386.3. [Q8IWX5-1]
DR   RefSeq; XP_016858844.1; XM_017003355.1. [Q8IWX5-2]
DR   UniGene; Hs.210043; -.
DR   UniGene; Hs.591604; -.
DR   ProteinModelPortal; Q8IWX5; -.
DR   STRING; 9606.ENSP00000315137; -.
DR   SwissLipids; SLP:000000159; -.
DR   DEPOD; Q8IWX5; -.
DR   PhosphoSitePlus; Q8IWX5; -.
DR   BioMuta; SGPP2; -.
DR   DMDM; 41700844; -.
DR   EPD; Q8IWX5; -.
DR   PaxDb; Q8IWX5; -.
DR   PeptideAtlas; Q8IWX5; -.
DR   PRIDE; Q8IWX5; -.
DR   Ensembl; ENST00000321276; ENSP00000315137; ENSG00000163082. [Q8IWX5-1]
DR   GeneID; 130367; -.
DR   KEGG; hsa:130367; -.
DR   UCSC; uc010zlo.3; human. [Q8IWX5-1]
DR   CTD; 130367; -.
DR   DisGeNET; 130367; -.
DR   GeneCards; SGPP2; -.
DR   HGNC; HGNC:19953; SGPP2.
DR   MIM; 612827; gene.
DR   neXtProt; NX_Q8IWX5; -.
DR   OpenTargets; ENSG00000163082; -.
DR   PharmGKB; PA134956234; -.
DR   eggNOG; KOG2822; Eukaryota.
DR   eggNOG; COG0671; LUCA.
DR   GeneTree; ENSGT00390000017322; -.
DR   HOGENOM; HOG000234228; -.
DR   HOVERGEN; HBG079185; -.
DR   InParanoid; Q8IWX5; -.
DR   KO; K04717; -.
DR   OMA; LPCIHWN; -.
DR   OrthoDB; EOG091G092E; -.
DR   PhylomeDB; Q8IWX5; -.
DR   TreeFam; TF323419; -.
DR   Reactome; R-HSA-1660661; Sphingolipid de novo biosynthesis.
DR   ChiTaRS; SGPP2; human.
DR   GenomeRNAi; 130367; -.
DR   PRO; PR:Q8IWX5; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000163082; -.
DR   CleanEx; HS_SGPP2; -.
DR   Genevisible; Q8IWX5; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0070780; F:dihydrosphingosine-1-phosphate phosphatase activity; TAS:Reactome.
DR   GO; GO:0042392; F:sphingosine-1-phosphate phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome.
DR   GO; GO:0006670; P:sphingosine metabolic process; IDA:UniProtKB.
DR   Gene3D; 1.20.144.10; -; 1.
DR   InterPro; IPR000326; P_Acid_Pase_2/haloperoxidase.
DR   Pfam; PF01569; PAP2; 1.
DR   SMART; SM00014; acidPPc; 1.
DR   SUPFAM; SSF48317; SSF48317; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; Endoplasmic reticulum;
KW   Hydrolase; Membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    399       Sphingosine-1-phosphate phosphatase 2.
FT                                /FTId=PRO_0000114480.
FT   TRANSMEM     88    108       Helical. {ECO:0000255}.
FT   TRANSMEM    121    141       Helical. {ECO:0000255}.
FT   TRANSMEM    160    180       Helical. {ECO:0000255}.
FT   TRANSMEM    185    205       Helical. {ECO:0000255}.
FT   TRANSMEM    219    239       Helical. {ECO:0000255}.
FT   TRANSMEM    247    267       Helical. {ECO:0000255}.
FT   TRANSMEM    280    300       Helical. {ECO:0000255}.
FT   TRANSMEM    318    338       Helical. {ECO:0000255}.
FT   TRANSMEM    371    391       Helical. {ECO:0000255}.
FT   VAR_SEQ       1    128       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_039385.
SQ   SEQUENCE   399 AA;  44741 MW;  7615BA231263D0B6 CRC64;
     MAELLRSLQD SQLVARFQRR CGLFPAPDEG PRENGADPTE RAARVPGVEH LPAANGKGGE
     APANGLRRAA APEAYVQKYV VKNYFYYYLF QFSAALGQEV FYITFLPFTH WNIDPYLSRR
     LIIIWVLVMY IGQVAKDVLK WPRPSSPPVV KLEKRLIAEY GMPSTHAMAA TAIAFTLLIS
     TMDRYQYPFV LGLVMAVVFS TLVCLSRLYT GMHTVLDVLG GVLITALLIV LTYPAWTFID
     CLDSASPLFP VCVIVVPFFL CYNYPVSDYY SPTRADTTTI LAAGAGVTIG FWINHFFQLV
     SKPAESLPVI QNIPPLTTYM LVLGLTKFAV GIVLILLVRQ LVQNLSLQVL YSWFKVVTRN
     KEARRRLEIE VPYKFVTYTS VGICATTFVP MLHRFLGLP
//
